Similar articles

• In vivo characterization of myocardium muscarinic receptors by positron emission tomography.

  Mazière M, Comar D, Godot JM, Collard P, Cepeda C, Naquet R. Mazière M, et al. Life Sci. 1981 Dec 7;29(23):2391-7. doi: 10.1016/0024-3205(81)90475-6. Life Sci. 1981. PMID: 6976499 No abstract available.
• Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors.

  Abood LG, Saraswati M, Lerner-Marmarosh N, Hashmi M. Abood LG, et al. Biochem Pharmacol. 1993 May 25;45(10):2143-8. doi: 10.1016/0006-2952(93)90028-u. Biochem Pharmacol. 1993. PMID: 8512596
• The distribution of the muscarinic acetylcholine receptor antagonists, quinuclidinyl benzilate and quinuclidinyl benzilate methiodide (both tritiated), in rat, guinea pig, and rabbit.

  Gibson RE, Eckelman WC, Vieras F, Reba RC. Gibson RE, et al. J Nucl Med. 1979 Aug;20(8):865-70. J Nucl Med. 1979. PMID: 541735
• Cholinergic neurotransmission studied in vivo using positron emission tomography or single photon emission computerized tomography.

  Maziere M. Maziere M. Pharmacol Ther. 1995 Apr;66(1):83-101. doi: 10.1016/0163-7258(95)00003-y. Pharmacol Ther. 1995. PMID: 7630931 Review.
• Cholinergic receptors in the rat and human brain: microscopic visualization.

  Palacios JM, Mengod G, Vilaró MT, Wiederhold KH, Boddeke H, Alvarez FJ, Chinaglia G, Probst A. Palacios JM, et al. Prog Brain Res. 1990;84:243-53. doi: 10.1016/s0079-6123(08)60909-7. Prog Brain Res. 1990. PMID: 2267301 Review. No abstract available.